XML 27 R21.htm IDEA: XBRL DOCUMENT v3.25.1
Balance Sheet Components (Tables)
3 Months Ended
Mar. 31, 2025
Disclosure Of Balance Sheet Components [Abstract]  
Schedule of Reconciliation of Cash, Cash Equivalents and Restricted Cash

The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the unaudited condensed consolidated balance sheets that sum to the total of the same amounts shown in the unaudited condensed consolidated statements of cash flows (in thousands):

 

 

 

March 31,
2025

 

 

December 31,
2024

 

Cash

$

12,735

 

 

$

2,651

 

Cash equivalents

 

84,387

 

 

 

46,847

 

Cash and cash equivalents

 

 

97,122

 

 

 

49,498

 

Restricted cash

 

1,032

 

 

 

1,032

 

Cash, cash equivalents and restricted cash

$

98,154

 

 

$

50,530

 

Summary of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in thousands):

 

 

 

March 31,
2025

 

 

December 31,
2024

 

Prepaid research and development costs

 

$

2,968

 

 

$

2,640

 

Prepaid insurance

 

 

424

 

 

 

700

 

Prepaid and other current assets

 

 

1,074

 

 

 

1,104

 

Total prepaid expenses and other current assets

 

$

4,466

 

 

$

4,444

 

Summary of Property and Equipment, Net

Property and equipment, net, consisted of the following (in thousands):

 

 

 

March 31,
2025

 

 

December 31,
2024

 

Leasehold improvements

 

$

17,254

 

 

$

17,254

 

Laboratory equipment

 

 

1,871

 

 

 

1,838

 

Furniture and fixtures

 

 

730

 

 

 

692

 

Computer equipment and software

 

 

39

 

 

 

33

 

Construction in progress

 

 

12

 

 

 

 

Total property and equipment, gross

 

 

19,906

 

 

 

19,817

 

Less: accumulated depreciation

 

 

(7,716

)

 

 

(7,179

)

Total property and equipment, net

 

$

12,190

 

 

$

12,638

 

Summary of Accrued and Other Current Liabilities

Accrued and other current liabilities consisted of the following (in thousands):

 

 

 

March 31,
2025

 

 

December 31,
2024

 

Accrued research and development expenses

 

$

17,409

 

 

$

10,992

 

Accrued compensation

 

 

2,372

 

 

 

5,833

 

Accrued professional services

 

 

474

 

 

 

602

 

Other accrued and current liabilities

 

 

239

 

 

 

141

 

Total accrued and other current liabilities

 

$

20,494

 

 

$

17,568